Spinal cord astrocytoma: Response to PCV chemotherapy

John W. Henson, Allan F. Thornton, David N. Louis

Research output: Contribution to journalArticlepeer-review

19 Scopus citations


Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.

Original languageEnglish (US)
Pages (from-to)518-520
Number of pages3
Issue number2
StatePublished - Jan 25 2000
Externally publishedYes


  • Astrocytoma
  • Chemotherapy
  • Spinal neoplasm

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Spinal cord astrocytoma: Response to PCV chemotherapy'. Together they form a unique fingerprint.

Cite this